Wedbush Has Lowered Expectations for Healthpeak Properties (NYSE:DOC) Stock Price

Healthpeak Properties (NYSE:DOC) had its target price dropped by equities research analysts at Wedbush from $27.00 to $24.00 in a report released on Friday,Benzinga reports. The brokerage presently has an “outperform” rating on the real estate investment trust’s stock. Wedbush’s price target would suggest a potential upside of 22.62% from the company’s previous close. Wedbush also issued estimates for Healthpeak Properties’ FY2025 earnings at $1.85 EPS and FY2026 earnings at $1.96 EPS.

A number of other brokerages have also commented on DOC. StockNews.com lowered shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Wednesday, October 30th. Wells Fargo & Company reduced their target price on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 10th. Mizuho reduced their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research report on Thursday, December 5th. Morgan Stanley raised shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 target price on the stock in a research report on Wednesday, January 15th. Finally, Robert W. Baird reduced their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research report on Tuesday, February 11th. One analyst has rated the stock with a sell rating, three have given a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $24.00.

Healthpeak Properties Stock Performance

Healthpeak Properties stock opened at $19.57 on Friday. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.31. Healthpeak Properties has a 1-year low of $16.01 and a 1-year high of $23.26. The firm has a market capitalization of $13.69 billion, a P/E ratio of 55.92, a price-to-earnings-growth ratio of 2.18 and a beta of 1.15. The company’s 50-day moving average is $20.36 and its 200 day moving average is $21.46.

Institutional Investors Weigh In On Healthpeak Properties

Several institutional investors have recently bought and sold shares of the company. Mercer Global Advisors Inc. ADV boosted its stake in Healthpeak Properties by 29.4% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 38,379 shares of the real estate investment trust’s stock valued at $778,000 after acquiring an additional 8,726 shares in the last quarter. Kapitalo Investimentos Ltda acquired a new stake in Healthpeak Properties in the fourth quarter valued at approximately $46,000. Northern Trust Corp lifted its stake in shares of Healthpeak Properties by 32.6% during the fourth quarter. Northern Trust Corp now owns 10,526,223 shares of the real estate investment trust’s stock worth $213,367,000 after buying an additional 2,590,530 shares during the period. Susquehanna Fundamental Investments LLC acquired a new stake in shares of Healthpeak Properties during the fourth quarter worth $16,450,000. Finally, Nebula Research & Development LLC lifted its stake in shares of Healthpeak Properties by 80.5% during the fourth quarter. Nebula Research & Development LLC now owns 64,110 shares of the real estate investment trust’s stock worth $1,300,000 after buying an additional 28,595 shares during the period. 93.57% of the stock is currently owned by institutional investors and hedge funds.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.